Bradda Head  Lithium exceeds targets, secures US$3 million royalty and moves closer to production. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 148.50
Bid: 147.80
Ask: 148.00
Change: 3.60 (2.48%)
Spread: 0.20 (0.135%)
Open: 146.00
High: 151.30
Low: 146.00
Prev. Close: 144.90
AML Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

8 Oct 2019 07:00

RNS Number : 0612P
Aston Martin Lagonda Global Hld PLC
08 October 2019
 

8 October 2019

This announcement contains inside information

Aston Martin Lagonda Global Holdings plc (the "Company")

Board and Committee Changes

 

The Company announces the following Board and Committee changes, with immediate effect. These changes relate to the shareholder representative directors and reflect the commitments given by the Adeem/Primewagon controlling shareholder group and the Investindustrial controlling shareholder group in their respective Relationship Agreements with the Company.

 

·; Mr Najeeb Al Humaidhi, the Representative of the Adeem/Primewagon controlling shareholder group, has nominated Mr Amr AbouelSeoud and Mr Mahmoud Samy Mohamed Aly El Sayed as their two continuing Adeem/Primewagon Non-Executive Directors. Mr Mahmoud Samy Mohamed Aly El Sayed has been appointed as the Adeem/Primewagon representative director on the Nomination Committee.

 

·; As provided in the Relationship Agreements, Mr Peter Rogers and Mr Mahmoud Samy will now serve as observers on the Audit and Risk Committee with no voting rights. They will remain on the Board as Non-Executive Directors.

 

·; As provided in the Relationship Agreements, Mr Dante Razzano and Mr Amr AbouelSeoud will now serve as observers on the Remuneration Committee with no voting rights. They will remain on the Board as Non-Executive Directors.

 

Following the above changes, the Company is now compliant with the UK Corporate Governance Code in relation to the composition of its Audit and Risk and Remuneration Committees. To achieve Board Code compliance, we are in discussion with independent non-executive director candidates and expect to announce the outcome shortly.

The Company thanks Messrs. Najeeb Al Humaidhi and Saoud Al Humaidhi for their service as directors in its first year since IPO and thanks them for their long-standing and continuing support as shareholders.

 

 

Enquiries:

 

Investors and Analysts

Charlotte Cowley, Director of Investor Relations +44 (0)7771 976764 charlotte.cowley@astonmartin.com

Media

Kevin Watters, Director of Communications +44 (0)7764 386683

kevin.watters@astonmartin.com

Grace Barnie, Corporate Communications Manager +44 (0)7880 903490 grace.barnie@astonmartin.com

 

Brunswick

Dan Roberts, Andrew Porter, Diana Vaughton +44 (0)20 7404 5959 astonmartin@brunswickgroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUGGGWUUPBPUM
Date   Source Headline
10th Jun 20249:47 amRNSDirector/PDMR Shareholding
9th May 20247:00 amRNSIssue of equity to satisfy employee share awards
8th May 202412:12 pmRNSAGM voting results
2nd May 20244:11 pmRNSDirector/PDMR Shareholding
1st May 20242:59 pmRNSESEF Annual Report 2023
1st May 20247:00 amRNSQ1 results for three months ended 31 March 2024
8th Apr 20249:00 amRNSAnnual Report 2023 and Notice of AGM
28th Mar 20244:10 pmRNSDirector Declaration
22nd Mar 20248:28 amRNSAppointment of New Chief Executive Officer
13th Mar 20246:16 pmRNSSuccessful pricing of £1.15 billion refinancing
12th Mar 20243:33 pmRNSHolding(s) in Company
11th Mar 20247:36 amRNSLaunch of Notes Offering
4th Mar 20249:05 amRNSIssue of equity to satisfy share awards
28th Feb 20247:00 amRNSPreliminary Results year ended 31 December 2023
20th Dec 20239:32 amRNSHolding(s) in Company
20th Dec 20239:31 amRNSHolding(s) in Company
8th Nov 20233:46 pmRNSHolding(s) in Company
8th Nov 20233:41 pmRNSHolding(s) in Company
8th Nov 20238:00 amRNSHolding(s) in Company
7th Nov 20233:23 pmRNSHolding(s) in Company
3rd Nov 202310:18 amRNSDirector/PDMR Shareholding
2nd Nov 20238:00 amRNSAdmission of shares and total voting rights
1st Nov 20237:00 amRNS3rd Quarter Results
30th Oct 20237:00 amRNSDirectorate Change
3rd Oct 20232:14 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:13 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:10 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:10 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:07 pmRNSHolding(s) in Company
29th Sep 20237:00 amRNSIncreased investment by Yew Tree Consortium
19th Sep 202311:53 amRNSResult of Meeting
29th Aug 202312:01 pmRNSPublication of Circular and Notice of GM
4th Aug 20234:45 pmRNSHolding(s) in Company
4th Aug 20231:05 pmRNSDirector/PDMR Shareholding
4th Aug 202312:43 pmRNSDirector/PDMR Shareholding
4th Aug 202312:33 pmRNSDirector/PDMR Shareholding
4th Aug 202312:32 pmRNSDirector/PDMR Shareholding
4th Aug 202312:21 pmRNSHolding(s) in Company
1st Aug 20237:00 amRNSResult of Equity Issue
31st Jul 20234:41 pmRNSRetail Offer
31st Jul 20234:40 pmRNSProposed Share Placing
28th Jul 20237:00 amRNSAppointment of Non-executive Director
26th Jul 20232:49 pmRNSTotal Voting Rights
26th Jul 20237:00 amRNSHalf-year Report
14th Jul 202312:18 pmRNSHolding(s) in Company
10th Jul 20234:34 pmRNSReplacement Listing and Total Voting Rights
10th Jul 20238:56 amRNSAdditional Listing and Total Voting Rights
6th Jul 20238:16 amRNSHolding(s) in Company
3rd Jul 20237:00 amRNSAdmission of New Shares for Warrant exercise
27th Jun 20237:00 amRNSCapital Markets Day 2023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.